Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale L Barnard

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Antiviral Research|August 16, 2016
Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 miceAlmut H Vollmer, Makda S Gebre, Dale L Barnard
Antiviral Research|October 25, 2016
Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in miceDonald F Smee, Dale L Barnard, Steven M Jones
Current Protocols in Microbiology|May 5, 2010
Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP)Jason P Roth, Joseph K-K Li, Dale L Barnard
Antiviral Research|December 14, 2016
Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol<sup>®</sup> (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse modelYohichi Kumaki, Andres M Salazar, Miles K Wandersee, et al.
Antiviral Chemistry & Chemotherapy|July 10, 2008
Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virusDonald F Smee, Daniel E Humphreys, Brett L Hurst, et al.
Journal of Virological Methods|October 9, 2002
Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compoundsDonald F Smee, Ann C Morrison, Dale L Barnard, et al.
Antiviral Research|September 20, 2011
In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infectionsYohichi Kumaki, Craig W Day, Donald F Smee, et al.
Future Virology|February 25, 2014
Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in miceDonald F Smee, E Bart Tarbet, Yousuke Furuta, et al.
Antiviral Research|October 3, 2013
Favipiravir (T-705), a novel viral RNA polymerase inhibitorYousuke Furuta, Brian B Gowen, Kazumi Takahashi, et al.
Virus Genes|May 21, 2013
Deletion of the D domain of the human parainfluenza virus type 3 (HPIV3) PD protein results in decreased viral RNA synthesis and beta interferon (IFN-β) expressionJason P Roth, Joseph K-K Li, John D Morrey, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Antiviral Research|August 16, 2016
Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 miceAlmut H Vollmer, Makda S Gebre, Dale L Barnard
Antiviral Research|October 25, 2016
Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in miceDonald F Smee, Dale L Barnard, Steven M Jones
Current Protocols in Microbiology|May 5, 2010
Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP)Jason P Roth, Joseph K-K Li, Dale L Barnard
Antiviral Research|December 14, 2016
Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol<sup>®</sup> (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse modelYohichi Kumaki, Andres M Salazar, Miles K Wandersee, et al.
Antiviral Chemistry & Chemotherapy|July 10, 2008
Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virusDonald F Smee, Daniel E Humphreys, Brett L Hurst, et al.
Journal of Virological Methods|October 9, 2002
Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compoundsDonald F Smee, Ann C Morrison, Dale L Barnard, et al.
Antiviral Research|September 20, 2011
In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infectionsYohichi Kumaki, Craig W Day, Donald F Smee, et al.
Future Virology|February 25, 2014
Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in miceDonald F Smee, E Bart Tarbet, Yousuke Furuta, et al.
Antiviral Research|October 3, 2013
Favipiravir (T-705), a novel viral RNA polymerase inhibitorYousuke Furuta, Brian B Gowen, Kazumi Takahashi, et al.
Virus Genes|May 21, 2013
Deletion of the D domain of the human parainfluenza virus type 3 (HPIV3) PD protein results in decreased viral RNA synthesis and beta interferon (IFN-β) expressionJason P Roth, Joseph K-K Li, John D Morrey, et al.
Pageof 6